Home
CancerScanner Technology
Clinical Trial Results
Cancer Applications
Management
Investor Information
Contact Information

 

SpectraPath Technologies' unique, patented CancerScanner™ is the only Real-Time, Non-Invasive cancer detection system utilizing elastic light scattering technology. Our proprietary system allows physicians to quickly and inexpensively screen patients in Real-Time without requiring a costly and time-consuming biopsy for:

  • Skin Cancer
  • Cervical Cancer
  • Brain Cancer
  • Esophageal Cancer
  • Colorectal Cancer

Developed by the U.S. Department of Energy at Los Alamos National Laboratories Bioscience Division:

This cutting-edge white-light bio-detection technology has been exclusively licensed to SpectraPath Technologies.  SpectraPath has further developed and patented this technology into the CancerScanner™ real-time, non-invasive cancer detection device. See our Technology section.

A Revolution in Cancer Detection Technology:

SpectraPath's proprietary Elastic Light Scattering Spectroscopy (ELSS) system utilizes low-power white light to provide real-time, non-invasive and completely safe patient scanning.

The CancerScanner™ is small, lightweight and low-cost. It's economically practical for all hospital, physician office and patient services centers.

The CancerScanner™ is suitable for all Dermatologists, OB/Gyn's, Nerologists, Surgeons, Radiologists and Pathologists.


Extensive Clinical Testing:

The CancerScanner™ technology platform has been successfully testing in both animals and humans for a variety of cancer types. See our Clinical Trials and Cancer Applications sections

 

 

Latest Research Coming Soon!
In association with a major European university, SpectraPath has conducted additional human ex-vivo cancer tests for brain cancer. Read about the final results soon!
 
Copyright 2004 SpectraPath Technologies Inc.